Last reviewed · How we verify

NCT06957249

Clinical Study to Evaluate the Tooth Whitening Efficacy

Completed Phase 3 Last updated 3 September 2025
What this trial tests

Phase 3 trial testing Optic White 5%HP ActivShine Toothpaste in Whitening in 80 participants. Completed in 5 May 2025.

Timeline
25 April 2025
Primary endpoint
3 May 2025
5 May 2025

Quick facts

Lead sponsorColgate Palmolive
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment80
Start date25 April 2025
Primary completion3 May 2025
Estimated completion5 May 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Colgate Palmolive — full company profile →

Who can join

Adults 18 to 70, any sex, with Whitening. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Optic White 5%HP ActivShine TP vs Crest3D White TP (head-to-head whitening clinical) The objective of this study is to evaluate the tooth whitening efficacy of a Colgate toothpaste with 5% Hydrogen Peroxide and Fluoride compared to a toothpaste with 0% Hydrogen Peroxide and Fluoride over a one-week period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Colgate Palmolive trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06957249.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing